Shionogi raises C&O stake towards target level following tender
This article was originally published in Scrip
Executive Summary
Shionogi has moved closer to completing its acquisition of C&O Pharmaceutical Technology (Holdings) through a tender offer which has raised its holding in the Chinese pharmaceutical firm to 63.8%.